- Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
-
Park J, Cheon JH
- KMID: 2382371
- Intest Res.
- 2017 Jul;15(3):263-265.
- doi: 10.5217/ir.2017.15.3.263
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Adalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study
-
Song WJ, Kang B, Choi SY, Choe YH
- KMID: 2328172
- Pediatr Gastroenterol Hepatol Nutr.
- 2016 Jun;19(2):116-122.
- doi: 10.5223/pghn.2016.19.2.116
PURPOSE: We aimed to investigate the efficacy and safety of adalimumab in pediatric-onset Crohn's disease patients who had failed treatment with infliximab. METHODS: In this retrospective study, patients included were those... -
- CITED
-
- Close
- SHARE
-
- Close
- Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
-
Im JP
- KMID: 2425154
- Intest Res.
- 2017 Apr;15(2):147-148.
- doi: 10.5217/ir.2017.15.2.147
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- New-onset Psoriasis Induced by Adalimumab Administered for Rheumatoid Arthritis
-
Suh HY, Kim KH, Ahn JY, Park MY, Youn JI
- KMID: 2391181
- Korean J Dermatol.
- 2017 Aug;55(7):480-482.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
-
Shin S, Chung KY, Kim DS
- KMID: 2164657
- Ann Dermatol.
- 2016 Jun;28(3):402-403.
- doi: 10.5021/ad.2016.28.3.402
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis
-
Park JW, Seok HY, Kim Y, Kim BJ
- KMID: 2376028
- J Clin Neurol.
- 2017 Apr;13(2):209-211.
- doi: 10.3988/jcn.2017.13.2.209
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Eruptive Benign Melanocytic Nevi Formation Following Adalimumab Therapy in a Patient with Crohn's Disease
-
Moon IJ, Won CH, Lee MW, Choi JH, Chang SE
- KMID: 2368135
- Ann Dermatol.
- 2016 Dec;28(6):777-779.
- doi: 10.5021/ad.2016.28.6.777
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Recurrent Vogt-Koyanagi-Harada Disease Successfully Treated with Adalimumab in Young Female Adult Patient
-
Kwon HY, Woo SJ
- KMID: 2469293
- Korean J Ophthalmol.
- 2020 Feb;34(1):92-93.
- doi: 10.3341/kjo.2019.0052
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
-
Kim JH, Cheon JH
- KMID: 2363960
- Gut Liver.
- 2016 Mar;10(2):162-163.
- doi: 10.5009/gnl16024
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Recalcitrant Pyoderma Gangrenosum with Ulcerative Colitis by Adalimumab Injection
-
Lee JH, Chang IK, Lee HE, Im M, Seo YJ, Lee JH, Lee Y
- KMID: 2394864
- Ann Dermatol.
- 2017 Apr;29(2):260-262.
- doi: 10.5021/ad.2017.29.2.260
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Adalimumab-induced Lupus Erythematosus Profundus in a Rheumatoid Arthritis Patient
-
Han G, Kim SA, Cho JW, Lee KS
- KMID: 2301512
- Korean J Dermatol.
- 2015 May;53(4):319-323.
The clinical manifestations and immunohistologic findings of drug-induced lupus erythematosus (DILE) are similar to those of idiopathic lupus. However, DILE is different from idiopathic lupus because it is induced after... -
- CITED
-
- Close
- SHARE
-
- Close
- Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis
-
Seol JE, Park IH, Lee W, Kim H, Jung SY, Wang HY
- KMID: 2344835
- Ann Dermatol.
- 2016 Aug;28(4):522-523.
- doi: 10.5021/ad.2016.28.4.522
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Tuberculosis Cutis Orificialis in Adalimumab Related Immunosupressive Patient
-
Iskandarli M, Gerceker Turk B, Yaman B, Ceylan N, Ceylan C
- KMID: 2368043
- Ann Dermatol.
- 2017 Feb;29(1):114-116.
- doi: 10.5021/ad.2017.29.1.114
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Adalimumab Induced Acute Exacerbation of Rheumatoid Arthritis Related Interstitial Lung Disease
-
Park WK, Lee YS, Won S, Kim HR, Lee JH, Lee KB, Kim JH
- KMID: 2188251
- J Korean Geriatr Soc.
- 2013 Sep;17(3):134-137.
- doi: 10.4235/jkgs.2013.17.3.134
A 69-year-old woman with 6 years history of seropositive rheumatoid arthritis (RA) and asymptomatic interstitial lung disease (ILD) began taking adalimumab for ongoing arthritis despite intakes of sulfasalazine and hydroxychloroquine... -
- CITED
-
- Close
- SHARE
-
- Close
- Granuloma Annulare Induced by Adalimumab
-
Oh YJ, Choi WJ, Ko JY, Ro YS
- KMID: 2247582
- Korean J Dermatol.
- 2011 Jul;49(7):656-659.
Adalimumab is the first fully humanized monoclonal anti-tumor necrosis factor alpha (TNF-alpha) antibody. This drug has been shown to be of benefit in patients with inflammatory diseases in which TNF-alpha... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Treatment of Refractory Cutaneous Polyarteritis Nodosa with Adalimumab
-
Ahn E, So MW
- KMID: 2429715
- J Rheum Dis.
- 2018 Oct;25(4):302-305.
- doi: 10.4078/jrd.2018.25.4.302
Cutaneous polyarteritis nodosa (CPAN) is a form of necrotizing vasculitis of the medium and small-sized arteries. The condition is limited to the skin and there is a lack of visceral... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease
-
Ji CC, Takano S
- KMID: 2425159
- Intest Res.
- 2017 Apr;15(2):182-186.
- doi: 10.5217/ir.2017.15.2.182
BACKGROUND/AIMS: Infliximab has proven to be effective in the treatment of perianal fistulas in Crohn's disease (CD) but the efficacy of adalimumab is still unclear. The aim of this study... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Efficacy and Safety of Secukinumab and Adalimumab in Patients with Active Ankylosing Spondylitis: A Bayesian Network Meta-analysis of Randomized Controlled Trials
-
Lee YH, Song GG
- KMID: 2389062
- J Rheum Dis.
- 2017 Aug;24(4):211-219.
- doi: 10.4078/jrd.2017.24.4.211
OBJECTIVE: This study assessed the efficacy and safety of secukinumab and adalimumab in patients with active ankylosing spondylitis (AS). METHODS: A Bayesian network meta-analysis was performed with direct and indirect data... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response?
-
Jung JM, Lee YJ, Won CH, Chang SE, Lee MW, Choi JH, Moon KC
- KMID: 2171468
- Ann Dermatol.
- 2015 Oct;27(5):620-621.
- doi: 10.5021/ad.2015.27.5.620
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of Trough Serum Levels and Immunogenicity onLong-term Outcome of Adalimumab Therapy in Crohn's Disease(Gastroenterology 2009;137:1628-1640)
-
Seo GS
- KMID: 2284969
- Intest Res.
- 2009 Dec;7(2):135-136.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
